Bone Growth Stimulator Market by Product (Device, Boner Morphogenetic Protein, PRP), Application (Spinal Fusion, Delay Union & Non-union Bone Fracture, Oral-maxillofacial), End User (Hospitals, Home Care, Academia, CROs) - Global Forecasts to 2022

  • ID: 4232234
  • Report
  • Region: Global
  • 160 Pages
  • Markets and Markets
1 of 6
The Global Bone Growth Stimulator Market is Estimated to Reach USD 1.41 Billion by 2022, Growing at a CAGR of 5.4% Between 2017-2022

FEATURED COMPANIES

  • Arthrex, Inc.
  • Bioventus LLC
  • DJO Finance LLC
  • Ember Therapeutics Inc.
  • Isto Biologics
  • ITO Co., Ltd.
  • MORE

The global bone growth stimulators market is estimated to reach USD 1.41 billion by 2022, growing at a CAGR of 5.4% during the forecast period. The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population (including rising aging population and prevalence of obesity and diabetes) and cost-effectiveness and advantage of bone stimulation devices in bone fracture treatments over other alternative treatment options are some key factors propelling the growth of this market.

In this report, the market has been segmented on the basis of product, end user, application, and region. On the basis of application, the global bone growth stimulators market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, dental and maxillofacial surgeries, and other applications. In 2016, the spinal fusion surgeries segment accounted for the largest share of the market. This growth can be attributed to the established safety and efficacy of stimulators in fusion surgery, rising patient cases related to bone fracture, and growing number of spine procedures performed across the globe.

Geographically, North America commanded the largest share of the global bone growth stimulators market in 2016, followed by Europe. The growing elderly population, increasing incidence of arthritis and sports-related injuries, adoption of novel treatment options, and rising demand for minimally invasive spinal surgeries are some of the major factors driving the demand for bone growth stimulators in North America.

Report Coverage:

This report studies the global bone growth stimulators market based on product, application, and end user. The report also studies, factors (such as drivers, restraints, opportunities, and challenges) which affect market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes the micromarkets with respect to their individual growth trends, prospects, and contributions to the bone growth stimulators market.

Reasons to Buy the Report:

From an insights perspective, this research report is focused on various levels of analysis—industry trends and company profiles—which together discuss basic views on the competitive landscape, emerging, and high growth segments of the bone growth stimulators market, and high growth regions and their respective drivers, restraints, opportunities, and challenges.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market and in turn help firms garner greater shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the major players in the bone growth stimulators market. The report analyzes the market based on product, application, end user, and region.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the bone growth stimulators market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various bone growth stimulators across geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bone growth stimulators market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the bone growth stimulators market.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Arthrex, Inc.
  • Bioventus LLC
  • DJO Finance LLC
  • Ember Therapeutics Inc.
  • Isto Biologics
  • ITO Co., Ltd.
  • MORE
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.3 Market Size Estimation Methodology
2.3 Opportunity Indicators
2.3.1.1 Rapid Growth in the Geriatric Population
2.3.1.2 Healthcare Expenditure Patterns
2.3.1.3 Significant Number of Road Accidents
2.4 Market Data Validation and Triangulation
2.4.1 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Bone Growth Stimulators: Market Snapshot (2017-2022)
4.2 Geographic Analysis: Bone Growth Stimulator Market, By Type (2017)
4.3 Global Bone Growth Stimulator Market, By Application, 2017 vs 2022
4.4 Global Market Size, By End User, 2017 vs 2022 (USD Million)
4.5 Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Major Market Drivers
5.2.1.1 Growing Patient Preference for Noninvasive and Minimally Invasive Surgical Treatments
5.2.1.2 Increasing Target Patient Population
5.2.1.3 Procedural Benefits Offered By Bone Stimulation Devices in Bone Fracture Treatment
5.2.2 Major Market Restraints
5.2.2.1 Limited Medical Reimbursement for Bone Stimulation Products
5.2.2.2 High Treatment Costs Associated With BMP and PRP Products
5.2.3 Major Market Opportunities
5.2.3.1 Emerging Markets
5.2.4 Major Market Challenges
5.2.4.1 Lawsuits Filed Against Major Market Players Affecting the Brand Value
5.2.4.2 Side Effects Associated With BMP-Based Orthopedic Treatment

6 Industry Trends
6.1 Introduction
6.2 Key Industry Trends
6.2.1 Off-Label Use of BMP Products
6.2.2 Increasing Use of PRP in Other Applications
6.3 Supply Chain Analysis
6.4 Porter’s Five Forces Analysis

7 Global Bone Growth Stimulator Market, By Product
7.1 Introduction
7.2 Bone Growth Stimulation Devices
7.2.1 External Bone Growth Stimulators
7.2.1.1 Pulsed Electromagnetic Field Devices
7.2.1.2 Capacitive Coupling Devices
7.2.1.3 Combined Magnetic Field Devices
7.2.2 Implanted Bone Growth Stimulators
7.2.3 Ultrasonic Bone Growth Stimulators
7.3 Bone Morphogenetic Proteins
7.4 Platelet-Rich Plasma

8 Global Bone Growth Stimulator Market, By Application
8.1 Introduction
8.2 Spinal Fusion Surgeries
8.3 Delayed Union & Nonunion Bone Fractures
8.4 Oral and Maxillofacial Surgeries
8.5 Other Applications

9 Global Bone Growth Stimulator Market, By End User
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Home Care
9.4 Academic & Research Institutes and CROS

10 Global Bone Growth Stimulator Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World

11 Competitive Landscape
11.1 Introduction
11.2 Vendor Dive Overview
11.2.1 Vanguards
11.2.2 Innovators
11.2.3 Dynamic Players
11.2.4 Emerging Players
11.3 Competitive Benchmarking
11.3.1 Product Offerings (For 23 Players)
11.3.2 Business Strategy (For 23 Players)

12 Company Profiles
12.1 Top Market Players
12.1.1 Orthofix International N.V.
12.1.1.1 Overview
12.1.1.2 Company Scorecard
12.1.1.2.1 Product Offerings
12.1.1.2.2 Business Strategy
12.1.1.3 Recent Developments (2013-2017)
12.1.1.3.1 Product Launches, Enhancements, and Approvals
12.1.1.3.2 Other Developments
12.1.2 DJO Finance LLC
12.1.2.1 Overview
12.1.2.2 Company Scorecard
12.1.2.2.1 Product Offerings
12.1.2.2.2 Business Strategy
12.1.3 Zimmer Biomet Holdings, Inc.
12.1.3.1 Overview
12.1.3.2 Company Scorecard
12.1.3.2.1 Product Offerings
12.1.3.2.2 Business Strategy
12.1.3.3 Recent Developments (2013-2017)
12.1.3.3.1 Mergers & Acquisitions
12.1.4 Bioventus LLC
12.1.4.1 Overview
12.1.4.2 Company Scorecard
12.1.4.2.1 Product Offerings
12.1.4.2.2 Business Strategy
12.1.4.3 Recent Developments (2013-2017)
12.1.4.3.1 Product Launches, Showcases, Enhancements, and Recognitions
12.1.4.3.2 Mergers & Acquisitions
12.1.4.3.3 Expansions
12.1.4.3.4 Agreements
12.1.5 Medtronic PLC
12.1.5.1 Overview
12.1.5.2 Company Scorecard
12.1.5.2.1 Product Offerings
12.1.5.2.2 Business Strategy
12.1.5.3 Recent Developments (2013-2017)
12.1.5.3.1 Product Launches, Enhancements, and Approvals
12.1.5.3.2 Expansion
12.1.6 Stryker Corporation
12.1.6.1 Overview
12.1.6.2 Company Scorecard
12.1.6.2.1 Product Offerings
12.1.6.2.2 Business Strategy
12.1.7 Depuy Synthes (A Subsidiary of Johnson & Johnson)
12.1.7.1 Overview
12.1.7.2 Company Scorecard
12.1.7.2.1 Product Offerings
12.1.7.2.2 Business Strategy
12.1.7.3 Recent Developments (2013-2017)
12.1.7.3.1 Product Launches, Enhancements, and Approvals
12.1.8 Arthrex, Inc.
12.1.8.1 Overview
12.1.8.2 Company Scorecard
12.1.8.2.1 Product Offerings
12.1.8.2.2 Business Strategy
12.1.8.3 Recent Developments (2013-2017)
12.1.8.3.1 Expansion
12.1.9 Isto Biologics
12.1.9.1 Overview
12.1.9.2 Company Scorecard
12.1.9.2.1 Product Offerings
12.1.9.2.2 Business Strategy
12.1.9.3 Recent Developments (2013-2017)
12.1.9.3.1 Acquisitions
12.1.10 Harvest Technologies (A Terumo BCT Company)
12.1.10.1 Overview
12.1.10.2 Company Scorecard
12.1.10.2.1 Product Offerings
12.1.10.2.2 Business Strategy
12.2 Emerging Market Players
12.2.1 Ossatec Benelux Ltd.
12.2.1.1 Overview
12.2.1.2 Company Scorecard
12.2.1.2.1 Product Offerings
12.2.1.3 Business Strategy
12.2.2 Ember Therapeutics Inc.
12.2.2.1 Overview
12.2.2.2 Company Scorecard
12.2.2.2.1 Product Offerings
12.2.2.3 Business Strategy
12.2.2.4 Recent Developments (2013-2017)
12.2.2.4.1 Mergers & Acquisitions
12.2.3 Regen Lab SA
12.2.3.1 Overview
12.2.3.2 Company Scorecard
12.2.3.2.1 Product Offerings
12.2.3.3 Business Strategy
12.2.4 Altis Biologics (Pty) Ltd.
12.2.4.1 Overview
12.2.4.2 Company Scorecard
12.2.4.2.1 Product Offerings
12.2.4.2.2 Business Strategy
12.2.5 ITO Co., Ltd.
12.2.5.1 Overview
12.2.5.2 Company Scorecard
12.2.5.2.1 Product Offerings
12.2.5.2.2 Business Strategy

13 Appendix
13.1 Discussion Guide

List of Tables

Table 1 Global Bone Growth Stimulators Market Size, By Product, 2015-2022 (USD Million)
Table 2 Global Bone Growth Stimulation Devices Market Size, By Type, 2015-2022 (USD Million)
Table 3 Global Bone Growth Stimulation Devices Market Size, By Region, 2015-2022 (USD Million)
Table 4 External Bone Growth Stimulator Market Size, By Type, 2015-2022 (USD Million)
Table 5 External Bone Growth Stimulators Market Size, By Region, 2015-2022 (USD Million)
Table 6 PEMF Devices Market Size, By Region, 2015-2022 (USD Million)
Table 7 CC Devices Market Size, By Region, 2015-2022 (USD Million)
Table 8 CMF Devices Market Size, By Region, 2015-2022 (USD Million)
Table 9 Implanted Bone Growth Stimulator Market Size, By Region, 2015-2022 (USD Million)
Table 10 Ultrasonic Bone Growth Stimulators Market Size, By Region, 2015-2022 (USD Million)
Table 11 Bone Morphogenetic Proteins Market Size, By Region, 2015-2022 (USD Million)
Table 12 Platelet-Rich Plasma Market Size, By Region, 2015-2022 (USD Million)
Table 13 Global Bone Growth Stimulator Market Size, By Application, 2015-2022 (USD Million)
Table 14 Market Size for Spinal Fusion Surgeries, By Region, 2015-2022 (USD Million)
Table 15 Market Size for Delayed Union and Nonunion Bone Fractures, By Region, 2015-2022 (USD Million)
Table 16 Market Size for Oral and Maxillofacial Surgeries, By Region, 2015-2022 (USD Million)
Table 17 Market Size for Other Applications, By Region, 2015-2022 (USD Million)
Table 18 Global Bone Growth Stimulator Market Size, By End User, 2015-2022 (USD Million)
Table 19 Global Market Size for Hospitals & Clinics, By Region, 2015-2022 (USD Million)
Table 20 Global Market Size for Home Care, By Region, 2015-2022 (USD Million)
Table 21 Global Market Size for Academic & Research Institutes and CROS, By Region, 2015-2022 (USD Million)
Table 22 Global Bone Growth Stimulator Market Size, By Region, 2015-2022 (USD Million)
Table 23 Market Size, By Country, 2015-2022 (USD Million)
Table 24 North America: Bone Growth Stimulator Market Size, By Country, 2015-2022 (USD Million)
Table 25 North America: Market Size, By Product, 2015-2022 (USD Million)
Table 26 North America: Bone Growth Stimulation Devices Market Size, By Type, 2015-2022 (USD Million)
Table 27 North America: External Bone Growth Stimulator Market Size, By Type, 2015-2022 (USD Million)
Table 28 North America: Market Size, By End User, 2015-2022 (USD Million)
Table 29 North America: Market Size, By Application, 2015-2022 (USD Million)
Table 30 U.S.: Market Size, By Product, 2015-2022 (USD Million)
Table 31 U.S.: Market Size, By Application, 2015-2022 (USD Million)
Table 32 Canada: Bone Growth Stimulator Market Size, By Product, 2015-2022 (USD Million)
Table 33 Canada: Market Size, By Application, 2015-2022 (USD Million)
Table 34 Europe: Bone Growth Stimulator Market Size, By Country, 2015-2022 (USD Million)
Table 35 Europe: Market Size, By Product, 2015-2022 (USD Million)
Table 36 Europe: Bone Growth Stimulation Devices Market Size, By Type, 2015-2022 (USD Million)
Table 37 Europe: External Bone Growth Stimulator Market Size, By Type, 2015-2022 (USD Million)
Table 38 Europe: Market Size, By End User, 2015-2022 (USD Million)
Table 39 Europe: Market Size, By Application, 2015-2022 (USD Million)
Table 40 Germany: Bone Growth Stimulator Market Size, By Product, 2015-2022 (USD Million)
Table 41 Germany: Market Size, By Application, 2015-2022 (USD Million)
Table 42 U.K.: Bone Growth Stimulator Market Size, By Product, 2015-2022 (USD Million)
Table 43 U.K.: Market Size, By Application, 2015-2022 (USD Million)
Table 44 France: Bone Growth Stimulator Market Size, By Product, 2015-2022 (USD Million)
Table 45 France: Market Size, By Application, 2015-2022 (USD Million)
Table 46 Rest of Europe: Market Size, By Product, 2015-2022 (USD Million)
Table 47 Rest of Europe: Market Size, By Application, 2015-2022 (USD Million)
Table 48 Asia-Pacific: Bone Growth Stimulator Market Size, By Country, 2015-2022 (USD Million)
Table 49 Asia-Pacific: Market Size, By Product, 2015-2022 (USD Million)
Table 50 Asia-Pacific: Bone Growth Stimulation Devices Market Size, By Type, 2015-2022 (USD Million)
Table 51 Asia-Pacific: External Bone Growth Stimulator Market Size, By Type, 2015-2022 (USD Million)
Table 52 Asia-Pacific: Market Size, By End User, 2015-2022 (USD Million)
Table 53 Asia-Pacific: Market Size, By Application, 2015-2022 (USD Million)
Table 54 Japan: Bone Growth Stimulator Market Size, By Product, 2015-2022 (USD Million)
Table 55 Japan: Market Size, By Application, 2015-2022 (USD Million)
Table 56 China: Bone Growth Stimulator Market Size, By Product, 2015-2022 (USD Million)
Table 57 China: Market Size, By Application, 2015-2022 (USD Million)
Table 58 India: Bone Growth Stimulator Market Size, By Product, 2015-2022 (USD Million)
Table 59 India: Market Size, By Application, 2015-2022 (USD Million)
Table 60 RoAPAC: Market Size, By Product, 2015-2022 (USD Million)
Table 61 RoAPAC: Market Size, By Application, 2015-2022 (USD Million)
Table 62 RoW: Bone Growth Stimulator Market Size, By Product, 2015-2022 (USD Million)
Table 63 RoW: Bone Growth Stimulation Devices Market Size, By Type, 2015-2022 (USD Million)
Table 64 RoW: External Bone Growth Stimulator Market Size, By Type, 2015-2022 (USD Million)
Table 65 RoW: Market Size, By End User, 2015-2022 (USD Million)
Table 66 RoW: Market Size, By Application, 2015-2022 (USD Million)

List of Figures

Figure 1 Global Bone Growth Stimulators Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Research Methodology: Top-Down Approach
Figure 5 Research Methodology: Bottom-Up Approach
Figure 6 Geriatric Population, By Region, 2015 vs 2030 vs 2050 (Million)
Figure 7 Healthcare Expenditure Across Major Countries, 2000-2014
Figure 8 Healthcare Expenditure Across Major Regions, 2000-2014
Figure 9 Number of Road Accidents Worldwide, 2010 vs 2014
Figure 10 Data Triangulation Methodology
Figure 11 Bone Growth Stimulators Market Size, By Product (2017 vs 2022)
Figure 12 Bone Growth Stimulation Devices Market Size, By Type (2017 vs 2022)
Figure 13 Bone Growth Stimulator Market Share, By End User (2017 vs 2022)
Figure 14 Market Size, By Application (2017 vs 2022)
Figure 15 Market Share, By Region (2016)
Figure 16 Increasing Target Patient Population-Primary Growth Driver of the Market
Figure 17 U.S. Commanded the Largest Share of the Bone Growth Stimulator Market in 2017
Figure 18 Spinal Fusion Surgeries Segment Will Continue to Dominate the Bone Growth Stimulator Market in 2022
Figure 19 Hospitals & Clinics Segment to Account for the Largest Share of the Global Bone Growth Stimulator Market in 2017
Figure 20 India and China are Lucrative Markets for Manufacturers of Bone Growth Stimulators
Figure 21 Supply Chain Analysis: Bone Growth Stimulators Industry (2016)
Figure 22 Market: Porter’s Five Forces Analysis (2016)
Figure 23 PRP, the Fastest-Growing Segment of the Global Market
Figure 24 Spinal Fusion Surgeries, the Fastest-Growing Application Segment of the Global Market
Figure 25 Hospitals & Clinics to Be the Fastest-Growing End-User Segment in the Global Bone Growth Stimulator Market
Figure 26 Asia-Pacific to Offer High Growth Potential in the Global Bone Growth Stimulators Market
Figure 27 North America: Market Snapshot
Figure 28 Europe: Market Snapshot
Figure 29 Asia-Pacific: Market Snapshot
Figure 30 Dive Chart
Figure 31 Orthofix International N.V.: Company Snapshot (2015)
Figure 32 Orthofix International N.V.: Product Offering Scorecard
Figure 33 Orthofix International N.V.: Business Strategy Scorecard
Figure 34 DJO Finance LLC: Company Snapshot (2015)
Figure 35 DJO Finance LLC: Product Offering Scorecard
Figure 36 DJO Finance LLC : Business Strategy Scorecard
Figure 37 Zimmer Biomet Holdings, Inc.: Company Snapshot (2015)
Figure 38 Zimmer Biomet Holdings, Inc.: Product Offering Scorecard
Figure 39 Zimmer Biomet Holdings, Inc.: Business Strategy Scorecard
Figure 40 Bioventus LLC: Product Offering Scorecard
Figure 41 Bioventus LLC: Business Strategy Scorecard
Figure 42 Medtronic PLC: Company Snapshot (2016)
Figure 43 Medtronic PLC: Product Offering Scorecard
Figure 44 Medtronic PLC: Business Strategy Scorecard
Figure 45 Stryker Corporation: Company Snapshot (2015)
Figure 46 Stryker Corporation: Product Offering Scorecard
Figure 47 Stryker Corporation: Business Strategy Scorecard
Figure 48 Johnson & Johnson: Company Snapshot (2016)
Figure 49 Johnson & Johnson: Product Offering Scorecard
Figure 50 Johnson & Johnson: Business Strategy Scorecard
Figure 51 Arthrex, Inc.: Product Offering Scorecard
Figure 52 Arthrex, Inc.: Business Strategy Scorecard
Figure 53 Isto Biologics: Product Offering Scorecard
Figure 54 Isto Biologics: Business Strategy Scorecard
Figure 55 Terumo Corporation: Company Snapshot (2015)
Figure 56 Terumo Corporation: Product Offering Scorecard
Figure 57 Terumo Corporation: Business Strategy Scorecard
Figure 58 Ossatec Benelux Ltd.: Product Offering Scorecard
Figure 59 Ossatec Benelux Ltd.: Business Strategy Scorecard
Figure 60 Ember Therapeutics, Inc.: Product Offering Scorecard
Figure 61 Ember Therapeutics, Inc.: Business Strategy Scorecard
Figure 62 Regen Lab SA: Product Offering Scorecard
Figure 63 Regen Lab SA: Business Strategy Scorecard
Figure 64 Altis Biologics (Pty) Ltd.: Product Offering Scorecard
Figure 65 Altis Biologics (Pty) Ltd.: Business Strategy Scorecard
Figure 66 ITO Co., Ltd: Product Offering Scorecard
Figure 67 ITO Co., Ltd: Business Strategy Scorecard
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Altis Biologics (Pty) Ltd.
  • Arthrex, Inc.
  • Bioventus LLC
  • DJO Finance LLC
  • Depuy Synthes (A Subsidiary of Johnson & Johnson)
  • Ember Therapeutics Inc.
  • Harvest Technologies (A Terumo BCT Company)
  • ITO Co., Ltd.
  • Isto Biologics
  • Medtronic PLC
  • Orthofix International N.V.
  • Regen Lab SA
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll